IV iron formulations and/or erythropoietin stimulating agents may be needed for the management of anemia in patients with advanced chronic kidney disease #health#dialysis#iron#ESA
IV iron formulations and/or erythropoietin stimulating agents may b... | Ecency
January 23, 2025. Kidney Facts. Electrolyte Disorders 2ikservices ·